Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Could the Combination of Two Non-Psychotropic Cannabinoids Counteract Neuroinflammation? Effectiveness of Cannabidiol Associated with Cannabigerol
Santa Mammana, Eugenio Cavalli, Agnese Gugliandolo, et al.
Medicina (2019) Vol. 55, Iss. 11, pp. 747-747
Open Access | Times Cited: 74

Showing 26-50 of 74 citing articles:

Antibiofilm and Immune-Modulatory Activity of Cannabidiol and Cannabigerol in Oral Environments—In Vitro Study
Hernan Garzón, Manuela Loaiza-Oliva, María Cecilia Martínez Pabón, et al.
Antibiotics (2024) Vol. 13, Iss. 4, pp. 342-342
Open Access | Times Cited: 3
Phytocannabinoids—Evaluation of their therapeutic role in neuroinflammation
Sharon L. Smith, Taurri Spurgeon, Ruarri Spurgeon, et al.
Exploration of Neuroprotective Therapy (2024), pp. 325-348
Open Access | Times Cited: 3
Phytocannabinoids: General Aspects and Pharmacological Potential in Neurodegenerative Diseases
Graziella dos Reis Rosa Franco, Scott D. Smid, Cláudio Viegas
Current Neuropharmacology (2020) Vol. 19, Iss. 4, pp. 449-464
Open Access | Times Cited: 27
Attenuation of Oxidative Stress and Inflammatory Response by Chronic Cannabidiol Administration Is Associated with Improved n-6/n-3 PUFA Ratio in the White and Red Skeletal Muscle in a Rat Model of High-Fat Diet-Induced Obesity
Patrycja Bielawiec, Ewa Harasim‐Symbor, Klaudia Sztolsztener, et al.
Nutrients (2021) Vol. 13, Iss. 5, pp. 1603-1603
Open Access | Times Cited: 22
Cannabis and Autoimmunity: Possible Mechanisms of Action
Valeria Giorgi, Daniela Marotto, Alberto Batticciotto, et al.
ImmunoTargets and Therapy (2021) Vol. Volume 10, pp. 261-271
Open Access | Times Cited: 20
Therapeutic potentials of cannabidiol: Focus on the Nrf2 signaling pathway
Marjan Talebi, Mohammad Mehdi Sadoughi, Seyed Abdulmajid Ayatollahi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115805-115805
Open Access | Times Cited: 8
Chronic administration of synthetic cannabidiol induces antidepressant effects involving modulation of serotonin and noradrenaline levels in the hippocampus
Melkamu Alemu Abame, Yang He, Song Wu, et al.
Neuroscience Letters (2020) Vol. 744, pp. 135594-135594
Closed Access | Times Cited: 22
Cannabinoids and sleep-wake cycle: The potential role of serotonin
Salar Vaseghi, Shirin Arjmandi-Rad, Mohammad Nasehi, et al.
Behavioural Brain Research (2021) Vol. 412, pp. 113440-113440
Closed Access | Times Cited: 19
Novel CBG Derivatives Can Reduce Inflammation, Pain and Obesity
Natalya M. Kogan, Yarden Lavi, Louise M. Topping, et al.
Molecules (2021) Vol. 26, Iss. 18, pp. 5601-5601
Open Access | Times Cited: 19
Evaluating the Antinociceptive Efficacy of Cannabidiol Alone or in Combination with Morphine Using the Formalin Test in Male and Female Mice
Diana E. Sepúlveda, Daniel P. Morris, Wesley M. Raup‐Konsavage, et al.
Cannabis and Cannabinoid Research (2021) Vol. 7, Iss. 5, pp. 648-657
Open Access | Times Cited: 19
The taste of neuroinflammation: Molecular mechanisms linking taste sensing to neuroinflammatory responses
Menizibeya O. Welcome, Nikos E. Mastorakis
Pharmacological Research (2021) Vol. 167, pp. 105557-105557
Closed Access | Times Cited: 18
Bioactivity of the cannabigerol cannabinoid and its analogues – the role of 3-dimensional conformation
Mohammed S. Salha, Henry Adenusi, John H. Dupuis, et al.
Organic & Biomolecular Chemistry (2023) Vol. 21, Iss. 22, pp. 4683-4693
Open Access | Times Cited: 7
The structurally diverse phytocannabinoids cannabichromene, cannabigerol and cannabinol significantly inhibit amyloid β‐evoked neurotoxicity and changes in cell morphology in PC12 cells
Dylan T. Marsh, Ayato Sugiyama, Yuta Imai, et al.
Basic & Clinical Pharmacology & Toxicology (2023) Vol. 134, Iss. 3, pp. 293-309
Open Access | Times Cited: 7
Modulation of Redox and Inflammatory Signaling in Human Skin Cells Using Phytocannabinoids Applied after UVA Irradiation: In Vitro Studies
Adam Wroński, Iwona Jarocka-Karpowicz, Arkadiusz Surażyński, et al.
Cells (2024) Vol. 13, Iss. 11, pp. 965-965
Open Access | Times Cited: 2
Exploratory Analysis of iPSCS-Derived Neuronal Cells as Predictors of Diagnosis and Treatment of Alzheimer Disease
Eugenio Cavalli, Giuseppe Battaglia, Maria Sofia Basile, et al.
Brain Sciences (2020) Vol. 10, Iss. 3, pp. 166-166
Open Access | Times Cited: 19
Acute Supplementation with Cannabidiol Does Not Attenuate Inflammation or Improve Measures of Performance following Strenuous Exercise
Brett W. Crossland, B. Rhett Rigby, Anthony A. Duplanty, et al.
Healthcare (2022) Vol. 10, Iss. 6, pp. 1133-1133
Open Access | Times Cited: 12
Evaluating Cannabis sativa L.’s neuroprotection potential: From bench to bedside
John Staton Laws, Scott D. Smid
Phytomedicine (2022) Vol. 107, pp. 154485-154485
Closed Access | Times Cited: 12
Novel Synthesis of C-Methylated Phytocannabinoids Bearing Anti-inflammatory Properties
Yarden Lavi, Natalya M. Kogan, Louise M. Topping, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 8, pp. 5536-5549
Open Access | Times Cited: 6
Targeting Nrf2 Signaling Pathway in Cancer Prevention and Treatment: The Role of Cannabis Compounds
Anna Rybarczyk, Aleksandra Majchrzak‐Celińska, Violetta Krajka‐Kuźniak
Antioxidants (2023) Vol. 12, Iss. 12, pp. 2052-2052
Open Access | Times Cited: 6
Meta-Analysis of Transcriptomic Data of Dorsolateral Prefrontal Cortex and of Peripheral Blood Mononuclear Cells Identifies Altered Pathways in Schizophrenia
Maria Cristina Petralia, Rosella Ciurleo, Andrea Saraceno, et al.
Genes (2020) Vol. 11, Iss. 4, pp. 390-390
Open Access | Times Cited: 16
Cannabis Phytochemicals: A Review of Phytocannabinoid Chemistry and Bioactivity as Neuroprotective Agents
Dylan T. Marsh, Scott D. Smid
Australian Journal of Chemistry (2020) Vol. 74, Iss. 6, pp. 388-404
Closed Access | Times Cited: 16
Effect of Cannabidiol on the Neural Glyoxalase Pathway Function and Longevity of Several C. elegans Strains Including a C. elegans Alzheimer’s Disease Model
Joel Frandsen, Prabagaran Narayanasamy
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 8, pp. 1165-1177
Closed Access | Times Cited: 10
Non-psychotropic phytocannabinoid interactions with voltage-gated sodium channels: An update on cannabidiol and cannabigerol
Mohammad‐Reza Ghovanloo, Sulayman D. Dib‐Hajj, Samuel J. Goodchild, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 10
Will Cannabigerol Trigger Neuroregeneration after a Spinal Cord Injury? An In Vitro Answer from NSC-34 Scratch-Injured Cells Transcriptome
Andrea Valeri, Luigi Chiricosta, Agnese Gugliandolo, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 2, pp. 117-117
Open Access | Times Cited: 9
Identification of Novel Cannabinoid CB2 Receptor Agonists from Botanical Compounds and Preliminary Evaluation of Their Anti-Osteoporotic Effects
Sijing Hu, Gang Cheng, Hao Zhou, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 702-702
Open Access | Times Cited: 9

Scroll to top